pd 153035 and 1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

pd 153035 has been researched along with 1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bold, G; Buchdunger, E; Frei, J; Furet, P; Lang, M; Lydon, N; Mett, H; Meyer, T; Mueller, M; Traxler, P	1

Other Studies

1 other study(ies) available for pd 153035 and 1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

Article	Year
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. Journal of medicinal chemistry, 1997, Oct-24, Volume: 40, Issue:22 Topics: 3T3 Cells; Animals; Antineoplastic Agents; Biological Availability; Drug Design; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred BALB C; Models, Chemical; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured	1997

Article

Year

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

Journal of medicinal chemistry, 1997, Oct-24, Volume: 40, Issue:22

Topics: 3T3 Cells; Animals; Antineoplastic Agents; Biological Availability; Drug Design; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred BALB C; Models, Chemical; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1997